Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)

NCT ID: NCT01298219

Last Updated: 2020-02-11

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

439 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-12-31

Study Completion Date

2011-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of the study is to evaluate the efficacy and safety of lubiprostone administration in subjects with Opioid-induced Bowel Dysfunction.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opioid-induced Bowel Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators
Care provider and outcomes assessor were also blinded for this double-blind trial.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lubiprostone

24 mcg capsules twice daily (BID)

Group Type EXPERIMENTAL

Lubiprostone

Intervention Type DRUG

24 mcg administered orally twice daily (BID)

Placebo

0 mcg capsules twice daily (BID)

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Matching placebo, 0 mcg administered orally twice daily (BID)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lubiprostone

24 mcg administered orally twice daily (BID)

Intervention Type DRUG

Placebo

Matching placebo, 0 mcg administered orally twice daily (BID)

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Amitiza No other names

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

A patient can be considered for eligibility to participate if he/she:

* Has been consistently treated for chronic, noncancer-related pain with any oral, transdermal, intravenous, or subcutaneous opioid for at least 30 days prior to screening
* Is diagnosed with OBD
* Is capable of utilizing an electronic diary to report daily spontaneous bowel movements (SBMs)
* Is willing to continue opioid therapy and discontinue the use of laxatives, stool softeners, and other concomitant medications affecting gastrointestinal motility throughout the study

Exclusion Criteria

A patient cannot be considered for eligibility to participate if he/she:

* Uses opioids for the treatment of cancer-related pain, abdominal pain, mechanical bowel obstructions, bowel disorders, and constipation not arising from opioid use, but instead attributable to dietary, neurologic, congenital, or endocrine disorders, scleroderma, and/or for the management of drug addiction
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sucampo Pharmaceuticals, Inc.

INDUSTRY

Sponsor Role collaborator

Sucampo Pharma Americas, LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Study Leader

Role: STUDY_DIRECTOR

Mallinckrodt

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

North Alabama Research Center

Athens, Alabama, United States

Site Status

Innovative Clinical Trials, Inc.

Birmingham, Alabama, United States

Site Status

Achieve Clinical Research

Birmingham, Alabama, United States

Site Status

Alabama Clinical Therapeutics

Birmingham, Alabama, United States

Site Status

G&L Research, LLC

Foley, Alabama, United States

Site Status

Healthscan Research

Montgomery, Alabama, United States

Site Status

River Region Research

Tallassee, Alabama, United States

Site Status

Anasazi Internal Medicine PC

Phoenix, Arizona, United States

Site Status

Aureas Research, Inc

Little Rock, Arkansas, United States

Site Status

Certified Clinical Research

Carmichael, California, United States

Site Status

California Clinical Research, Inc.

Davis, California, United States

Site Status

Family Medical Center

Foothill Ranch, California, United States

Site Status

South Orange County Surgical Medical Group

Laguna Hills, California, United States

Site Status

Clinical Trials Research

Lincoln, California, United States

Site Status

Clear Vision Research

Long Beach, California, United States

Site Status

Long Beach VA Medical Center

Long Beach, California, United States

Site Status

Clear Vision Research

Los Angeles, California, United States

Site Status

Facey Medical Foundation

Mission Hills, California, United States

Site Status

North County Clinical Research

Oceanside, California, United States

Site Status

SDS Clinical Trials, Inc.

Orange, California, United States

Site Status

Probe Clinical Research Corporation

Riverside, California, United States

Site Status

Probe Clinical Research Corporation - Santa Ana

Santa Ana, California, United States

Site Status

Westlake Medical Research

Westlake Village, California, United States

Site Status

Mountain View Clinical Research

Denver, Colorado, United States

Site Status

Meridien Research

Bradenton, Florida, United States

Site Status

Coastal Orthopedics & Pain Management

Bradenton, Florida, United States

Site Status

Florida Research & Testing, LLC

Clearwater, Florida, United States

Site Status

Avail Clinical Research

DeLand, Florida, United States

Site Status

S&W Clinical Research

Fort Lauderdale, Florida, United States

Site Status

Palm Springs Research Institute

Hialeah, Florida, United States

Site Status

Kendall South Medical Center, Inc.

Miami, Florida, United States

Site Status

Gastroenterology Group of Naples

Naples, Florida, United States

Site Status

Physicians Regional Medical Group

Naples, Florida, United States

Site Status

Ocala Rheumatology Research Center

Ocala, Florida, United States

Site Status

Paddock Park Clinical Research

Ocala, Florida, United States

Site Status

Journey Research, Inc.

Oldsmar, Florida, United States

Site Status

Compass Research

Orlando, Florida, United States

Site Status

Andres Patron, DO, PA

Pembroke Pines, Florida, United States

Site Status

Advent Clinical Research Centers

Pinellas Park, Florida, United States

Site Status

Gold Coast Research, LLC

Plantation, Florida, United States

Site Status

Orthopedic Research Institite

Royal Palm Beach, Florida, United States

Site Status

IC Research

Sanford, Florida, United States

Site Status

Sarasota Memorial Pain Care Center

Sarasota, Florida, United States

Site Status

Tampa Clinical Research

Tampa, Florida, United States

Site Status

Southeastern Regional Research Group

Columbus, Georgia, United States

Site Status

Better Health Clinical Research

Newnan, Georgia, United States

Site Status

Clinical Research Atlanta

Stockbridge, Georgia, United States

Site Status

Advanced Clinical Research

Boise, Idaho, United States

Site Status

Sonora Clinical Research

Boise, Idaho, United States

Site Status

Nautical Clinical Research

Meridian, Idaho, United States

Site Status

Anesthesia/Pain Control Indiana University School of Medicine

Chicago, Illinois, United States

Site Status

Knight Center for Integrated Health

Peoria, Illinois, United States

Site Status

Ridge Family Practice

Council Bluffs, Iowa, United States

Site Status

Lee Research Institute

Lenexa, Kansas, United States

Site Status

Kentucky Medical Research Center

Lexington, Kentucky, United States

Site Status

Bluegrass Internal Medicine

Owensboro, Kentucky, United States

Site Status

Horizon Research Group

Baton Rouge, Louisiana, United States

Site Status

Miray Medical Center

Brockton, Massachusetts, United States

Site Status

The Research Institute

Springfield, Massachusetts, United States

Site Status

Coastal Research

Weymouth, Massachusetts, United States

Site Status

Ashok Jain, MD

Dearborn, Michigan, United States

Site Status

Shores Medical Associates

Saint Clair Shores, Michigan, United States

Site Status

Mid-America Clinical Research LLC

St Louis, Missouri, United States

Site Status

Montana Medical Research, Inc.

Missoula, Montana, United States

Site Status

Independent Clinical Researchers

Las Vegas, Nevada, United States

Site Status

AB Clinical Trials

Las Vegas, Nevada, United States

Site Status

Clinical Research of South Nevada

Las Vegas, Nevada, United States

Site Status

Clinical Research Advantage, Inc.

Las Vegas, Nevada, United States

Site Status

Lab2Marche

Las Vegas, Nevada, United States

Site Status

Aloha Medical Center

Las Vegas, Nevada, United States

Site Status

Edison Medical Group

Edison, New Jersey, United States

Site Status

Clinical Research Program

Marlton, New Jersey, United States

Site Status

Albuquerque Clinical Trials

Albuquerque, New Mexico, United States

Site Status

Drug Trials America

Hartsdale, New York, United States

Site Status

Family Health Medical Services PLLC

Jamestown, New York, United States

Site Status

U of Rochester

Rochester, New York, United States

Site Status

Medical Frontiers

Carlisle, Ohio, United States

Site Status

Hightop Medical Research Center

Cincinnati, Ohio, United States

Site Status

Community Research

Cincinnati, Ohio, United States

Site Status

Community Research

Cincinnati, Ohio, United States

Site Status

Rapid Medical Research, Inc.

Cleveland, Ohio, United States

Site Status

Parsons Avenue Medical Center

Columbus, Ohio, United States

Site Status

Hometown Urgent Care

Groveport, Ohio, United States

Site Status

Northstar Medical Research, LLC

Middleburg Heights, Ohio, United States

Site Status

Pharmacotherpy Research Associates Inc

Zanesville, Ohio, United States

Site Status

COR Clinical Research, LLC

Oklahoma City, Oklahoma, United States

Site Status

Sooner Clinical Research

Oklahoma City, Oklahoma, United States

Site Status

Sunstone Medical Research

Medford, Oregon, United States

Site Status

Fanno Creek Clinic

Portland, Oregon, United States

Site Status

McMillen & Magargle

Mechanicsburg, Pennsylvania, United States

Site Status

Omega Medical Research

Warwick, Rhode Island, United States

Site Status

Hartwell Research Group

Anderson, South Carolina, United States

Site Status

Degarmo Institute of Medical Research

Greer, South Carolina, United States

Site Status

Pain Specialists of Charleston

North Charleston, South Carolina, United States

Site Status

Health Concepts

Rapid City, South Dakota, United States

Site Status

InvestiClin Research

Brentwood, Tennessee, United States

Site Status

SCRI Research Center

Germantown, Tennessee, United States

Site Status

Prevention & Strengthening Solutions, Inc.

Humboldt, Tennessee, United States

Site Status

FutureSearch Trials of Neurology & Sleep Lab

Austin, Texas, United States

Site Status

Jaron Winston, MD

Austin, Texas, United States

Site Status

KRK Medical Research

Dallas, Texas, United States

Site Status

FutureSearch Trials of Dallas, LP

Dallas, Texas, United States

Site Status

Pillar Clinical Research, LLC

Dallas, Texas, United States

Site Status

Galenos Research

Dallas, Texas, United States

Site Status

Diversified Medical Practice, P.A.

Houston, Texas, United States

Site Status

Clinical Trial Network

Houston, Texas, United States

Site Status

Dependable Clinical Research

Houston, Texas, United States

Site Status

Pioneer Research Solutions, Inc.

Houston, Texas, United States

Site Status

Bobby Huynh

Richardson, Texas, United States

Site Status

Sun Research Institute

San Antonio, Texas, United States

Site Status

Spring Clinical Research

Sugar Land, Texas, United States

Site Status

Pioneer Research Solutions

Sugar Land, Texas, United States

Site Status

Lifetree Clinical Research

Salt Lake City, Utah, United States

Site Status

ACR Research Salt Lake City

West Jordan, Utah, United States

Site Status

Virginia Research Center, LLC

Midlothian, Virginia, United States

Site Status

Pain Clinic-Heilig Hart Ziekenhuis Roeselare

Roeselare, Westlaan 123, Belgium

Site Status

Huisartsenpraktijk De Regenboog

Antwerp, , Belgium

Site Status

Dr Capiau - GP Practice

Wetteren, , Belgium

Site Status

St. Anne's University Hospital - centrum pro

Brno, , Czechia

Site Status

Nemocnice Jablonec nad Nisou, p.o.

Jablonec nad Nisou, , Czechia

Site Status

Ambulance bolesti, Krajska nemocnice Liberec

Liberec, , Czechia

Site Status

Klaudianova nemocnice Mlada Boleslav

Mladá Boleslav, , Czechia

Site Status

Clintrial s.r.o.

Prague, , Czechia

Site Status

Neurologicka ambulance

Prague, , Czechia

Site Status

Regional Hospital T. B., a.s.

Zlín, , Czechia

Site Status

Schmerzzentrum Berlin

Berlin, , Germany

Site Status

Schmerztherapeutische- Ärztezentrum Nordstadt

Hanover, , Germany

Site Status

Schmerz und Palliativzentrum

Wiesbaden, , Germany

Site Status

NZOZ Dom Sue Ryder prowadzony przez Pallmed Sp. z o.o.

Bydgoszcz, , Poland

Site Status

Hagakliniken

Gothenburg, , Sweden

Site Status

Karolinska University Hospita- Dept of Anaesthesia, Pain Div.

Stockholm, , Sweden

Site Status

S3 Clinical Research Centers

Vällingby, , Sweden

Site Status

ElyBridge Surgery

Ely, Cardiff, United Kingdom

Site Status

Randalstown Medical Practice

Randalstown, Co Antrim, United Kingdom

Site Status

Sea Road Surgery

Bexhill-on-Sea, E.Sussex, United Kingdom

Site Status

Sheepcot Medical Centre,

Watford, Herts, United Kingdom

Site Status

Fylde Coast Clinical Research Ltd

Blackpool, Lancsashire, United Kingdom

Site Status

Ballygomartin Group Practice

Belfast, Northern Ireland, United Kingdom

Site Status

The Waterfront Medical Centre

Barry, Wales, United Kingdom

Site Status

Valleyfield Health Center

Dunfermline, , United Kingdom

Site Status

Frome Medical Practice

Frome, , United Kingdom

Site Status

Mortimer Surgery

Reading, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Belgium Czechia Germany Poland Sweden United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OBD1033

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Abuse Potential of Buprenorphine/Naloxone
NCT00149539 TERMINATED PHASE2
SUBLOCADE Long-term Outcomes
NCT05860959 COMPLETED
Lofexidine for Inpatient Opiate Detox
NCT00235729 COMPLETED PHASE3
Oral Cannabidiol for Opioid Withdrawal
NCT04238754 COMPLETED PHASE1/PHASE2